Vivek Subbiah, MD of MD Anderson Cancer Center gives an overview of his presentation, which focused on the use of vemurafenib in patients with non small-cell lung cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Abstract 9074: Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with BRAFV600mutation.
Advertisement